INTRODUCTION
MoMuLV-based retroviral vector pUCMoTN (1) contains 5′-and 3′-long terminal repeats (LTRs) made up of U3-r-U5 sequences. Vector RNA is transcribed from the 5′-LTR promoter and contains r-U5 sequences at the 5′-end and U3-r sequences at the 3′-end. These sequences are required for reverse transcription. This vector also encodes for neo mRNA from the internal HSV tk promoter. In addition, downstream cellular RNAs may be transcribed from the 3′-LTR promoter (Fig. 1a) . A ψ signal sequence is responsible for packaging RNA into the virions. A dimer linkage structure within the ψ signal mediates dimerization and co-packaging of two copies of full-length vector RNA molecules. Therefore, with the inclusion of the ψ signal, neo and cellular RNAs may also be packaged within the vector particles and impede reverse transcription of co-packaged vector RNA.
We have previously developed a packaging retroviral vector pUCMoTN-PR3 in which nt 211-1039 (forming the MoMuLV ψ signal) have been deleted from their original location and cloned between U3-r and U5 sequences within the 5′-LTR (2) . In this study we investigate whether MoTN-PR3 vector particles can reverse transcribe and integrate to result in provirus DNA with the ψ signal duplicated in both the 5′-and 3′-LTRs and whether the HSV tk promoter and the proviral 3′-LTR promoter can give rise to transcripts that contain the ψ signal. We further investigate whether these non-vector RNAs can be packaged within the retroviral vector particles and, if so, whether these particles containing chimeric RNAs can efficiently replicate.
MATERIALS AND METHODS

Retroviral vectors
The packaging retroviral vector pUCMoTN-PR3 was constructed as described previously (3) . The parent vector pUCMoTN (1) served as a control.
Cell lines
NIH 3T3, Psi-2 (4) and PA317 (5) cell lines were cultured in α-MEM medium supplemented with 2 mM L-glutamine, antibiotic-antimycotic solution (100 U/ml penicillin, 100 µg/ml streptomycin, 0.25 µg/ml amphotericin; Gibco) and 10% fetal bovine serum (Hyclone) at 37_C in a humidified atmosphere with 5% CO 2 . The CEM-10 cell line was cultured in a similar fashion, except that RPMI 1640 medium was used.
Transfection and infection of mammalian cell lines
Both transfection of the ecotropic Psi-2 packaging cell line using pUCMoTN and pUCMoTN-PR3 vector DNA and infection of the amphotropic PA317 packaging cell line using MoTN and MoTN-PR3 vector particles released from the stably transduced a Psi-2 cells were carried out as described previously (3) . Vector particles released from both transfected Psi-2 and infected PA317 cells were then analysed as described below.
Vector particle titre determination
The titre of vector particles released from Psi-2 and PA317 transductants (50-100% confluent) was determined (3) by counting the number of G418 R colonies obtained 2-3 weeks post-infection of NIH 3T3 cells. The titre of vector particles released from PA317 cells was also determined using CEM-10 cells.
Genomic DNA cloning and Southern blot analysis
Genomic DNA isolated from PA317 cells infected with MOTN-PR3 vector particles was digested with XhoI and cloned into the pUC18 vector at the compatible SalI site. A kanamycin-resistant (Km R ) clone was selected. Cloned DNA was digested with StyI and analysed by Southern blot analysis (6) . The blots were probed with a 32 P-labelled 210 bp StyI fragment of pUCMoTN containing the r-U5 sequence.
Polymerase chain reaction (PCR) analysis
Genomic DNA was isolated (6) from PA317 cells infected with MoTN and MoTN-PR3 vector particles. PCR was performed using the PPT-5′ (5′-CCT ATA GAG TAC GAG CC) and Psi-3′ (5′-ACA GAT AAG TTG CTG GC) primer pair as described previously (7) .
Reverse transcription (RT)-PCR analysis
Total RNA isolation from PA317 cells infected with MoTN and MoTN-PR3 vector particles and from the Psi-2 cells transfected with pUCMoTN-PR3 vector DNA was carried out as described (8) . Ten millilitre culture supernatants from 50-100% confluent cells were centrifuged in a Ti 70.1 rotor at 60 000 r.p.m. for 4 h to pellet MoTN and MoTN-PR3 vector particles, which were then used to extract RNA (8) . RNA extracted from cells and vector particles was treated with DNase and used in RT-PCR as described previously (7) using Psi-3′ and Neo-3′ (5′-TCT TTC ATC CAG ATC ATC-3′) primers for reverse transcription and the PPT-5′/Psi-3′ and Neo-5′ (5′-CAA GAC CGA CCT GTC CGG 3′)/Neo-3′ primer pairs for PCR.
Northern blot analysis
Total cellular and vector particle RNAs (5 µg) were subjected to Northern blot analysis using a 32 P-labelled ψ signal-specific probe (5′-TAA ATC AGA CAT AGA CA) as described (6) .
RESULTS AND DISCUSSION
The packaging retroviral vector pUCMoTN-PR3 (2) U3-r-ψ-U5 sequences. Upon transfection of the Psi-2 (4) packaging cell line, expressing the MoMuLV gag, pol and env genes, the pUCMoTN-PR3 vector DNA should be transcribed to produce vector RNA from the 5′-LTR promoter and neo mRNA from the HSV tk promoter. These RNAs should terminate within the 3′-LTR at the end of the U3-r sequence. In addition, readthrough vector, readthrough neo and 3′-LTR promoter-driven cellular RNAs ending at the next available transcription termination site may also be generated (Fig. 1b) . Of these, only the vector and the readthrough vector RNAs will contain the ψ signal and therefore be packaged into vector particles. Subsequent infection of another packaging cell line, PA317 (5), with these vector particles should result in reverse transcription (9) , generating provirus DNA with the ψ signal duplicated within both the 5′-and 3′-LTRs. Transcripts produced from this proviral DNA that have one or duplicate copies of the ψ signal include vector RNA, readthrough vector RNA, readthrough neo RNA and 3′-LTR-driven downstream cellular RNAs. These vector and non-vector RNAs should be encapsidated into vector particles. Hence, it will be interesting to examine if the presence of chimeric non-vector RNAs interferes with packaging and/or reverse transcription.
Accuracy of reverse transcription and integration of packaging retroviral vectors
To this end, the vector particles released from transfected Psi-2 cells were used to infect PA317 cells. The structure of the 3′-LTR present within the proviral DNA produced as a result of reverse transcription and integration in these cells was then analysed as described above by Southern blot analysis of cloned 3′-LTR DNA sequences and by RT-PCR. Specific probe/primers were used to distinguish between 3′-LTRs containing U3-r-U5 versus U3-r-ψ-U5 sequences.
XhoI-digested genomic DNA from PA317 cells infected with MoTN-PR3 vector particles was cloned into the pUC18 vector at the compatible SalI site. A Km R clone, containing the neo gene and the 3′-LTR sequences of the proviral DNA and the downstream cellular DNA sequence up to the next available XhoI site, was selected. The structure of the 3′-LTR present in this clone was confirmed to be U3-r-ψ-U5 by Southern blot analysis of StyI-digested DNA. StyI cleaves within the r and the U5 sequences, but not within the ψ sequence (results not shown).
Genomic DNA from PA317 cells infected with MoTN and MoTN-PR3 vector particles was also analysed by PCR (Fig. 2a) . Reverse transcription was performed using the Psi-3′ primer followed by PCR using the PPT-5′/Psi-3′ primer pair.
The 5′ primer (PPT-5′) used in this PCR was designed against a sequence close to the polypurine tract (PPT) located upstream of the 3′-LTR. The 3′ primer (Psi-3′) was designed against a sequence present within the ψ signal. Thus, if the 3′-LTR was modified in MoTN-PR3-infected PA317 cells, a 604 bp product containing PPT-U3-r-ψ sequences would be amplified. A 604 bp PCR product was detected in samples analysed from PA317 cells infected with MoTN-PR3 vector particles (Fig. 2a, lane 3) . However, a 604 bp product was also detected when pUCMoTN-PR3 vector DNA was PCR amplified (Fig. 2a,  lane 4) . Similarly, a 745 bp PCR product was detected in samples analysed from PA317 cells infected with MoTN vector particles (Fig. 2a, lane 1) as well as in samples analysed from pUCMoTN vector DNA (Fig. 2a, lane 2) . No PCR product was expected in the last three samples. Careful analysis revealed that these products must have resulted from hybridization due to extensive sequence complementarity between the 5′ and the 3′ primer extention products followed by PCR amplification. Therefore, from this experiment alone it could not be concluded whether the 604 bp product detected in samples from MoTN-PR3-infected PA317 cells is due to PCR amplification of a modified 3′-LTR.
As readthrough RNAs containing PPT-U3-r-U5 sequences are likely to be synthesized in MoTN-PR3-infected PA317 cells but not in MoTN-infected PA317 cells or pUCMoTN-PR3 vector DNA-transfected Psi-2 cells, RNA produced in these cells was reverse transcribed using the Psi-3′ primer and PCR amplified using the PPT-5′/Psi-3′ primer pair (Fig. 2b) . Since only the 3′ primer is used during cDNA synthesis, only sequences present on the cDNA can be amplified during PCR. A 604 bp product was detected only in samples analysed from PA317 cells infected with MoTN-PR3 vector particles (Fig. 2b, lane 2) . No PCR product was detected in samples analysed from PA317 cells infected with MoTN vector particles (Fig. 2b, lane 1) or from Psi-2 cells transfected with pUCMoTN-PR3 vector DNA (Fig. 2b, lane 3) .
These results demonstrate that packaging retroviral vector particles containing RNAs with a r-ψ-U5 sequence at the 5′-end and a U3-r sequence at the 3′-end can, upon reverse transcription in the infected target cells, give rise to modified 5′-and 3′-LTRs containing U3-r-ψ-U5 sequences. 
Expression and co-packaging of ψ signal-containing non-vector RNAs
The composition of ψ signal-containing RNAs present in PA317 cells infected with MoTN and MoTN-PR3 vector particles and in vector particles released from these cells was determined by Northern blot analysis using a 32 P-labelled probe specific for the ψ signal (Fig. 3a) . This probe should hybridize to the vector and readthrough vector RNAs produced in MoTN-infected PA317 cells (Fig. 1a) and to the vector, readthrough vector, readthrough neo and 3′-LTR-driven cellular RNAs produced in MoTN-PR3-infected PA317 cells (Fig. 1b) . Our results indicate that the vector and readthrough vector RNAs transcribed from the 5′-LTR promoter are produced in MoTN-infected PA317 cells (Fig. 3a, lane 1) and are also packaged within vector particles released from these cells (Fig. 3a, lane 3) . Several additional bands corresponding to readthrough neo RNA transcribed from the HSV tk promoter and/or cellular RNAs transcribed from the modified 3′-LTR promoter can be detected in RNA analysed from MoTN-PR3-infected PA317 cells (Fig. 3a, lane 2) . Since a MoMuLV ψ signal-specific probe was used in this Northern blot analysis, all of these RNAs must contain the ψ signal. The vector RNA, readthrough vector RNA and some neo readthrough and/or downstream cellular RNAs are also packaged within the vector particles released from MoTN-PR3-infected cells (Fig. 3a, lane 4) .
The composition of RNAs packaged in the vector particles released from MoTN-PR3-infected PA317 cells was further characterized by RT-PCR analysis using neo and PPT-U3-r-ψ region-specific primers (Fig. 3b) . In addition to vector RNA, either readthrough vector and readthrough neo RNAs or downstream cellular RNAs contained the ψ signal. RT-PCR analysis using the PPT-5′/Psi-3′ primer pair revealed that although present in the cells (Fig. 2b, lane 2) , readthrough RNAs are not packaged in the vector particles released from MoTN-PR3-infected PA317 cells (Fig. 3b, lane 2) . Control RT-PCR using neo region-specific primers confirmed the presence of vector RNA in these particles (Fig. 3b, lane 1) . Since no readthrough RNA can be detected by RT-PCR, the ψ signal-containing RNAs (other than the vector RNA) detected in the Northern blot experiment (Fig. 3a) must correspond to downstream cellular RNAs.
Packaging retroviral vectors containing cellular RNAs fail to transduce the neo gene during subsequent rounds of infection
The titre of MoTN-PR3 vector particles was compared with that of MoTN vector particles released from transfected Psi-2 and infected PA317 cells (Table 1 ). The titres of MoTN and MoTN-PR3 vector particles released from the transfected Psi-2 cells (from which no neo or cellular RNA should be packaged) were 1.6 × 10 6 and 2.8 × 10 5 colony forming units (c.f.u.)/ml respectively (2) . In contrast, the titre of MoTN-PR3 vector particles released from infected PA317 cells was 0.0 c.f.u./ml; the titre of MoTN vector particles was 3.4 × 10 6 c.f.u./ml ( Table 1) .
These results indicate that the vector particles containing chimeric RNAs released from infected PA317 cells are non-infectious. Co-packaging of cellular RNAs in MoTN-PR3 vector particles released from infected PA317 cells is likely to interfere with reverse transcription, resulting in a 0.0 c.f.u./ml titre. 
Packaging retroviral vector particles released from infected PA317 cells do not interfere with the titre of infectious vector particles
The human CD 4 + lymphocyte-derived adherent CEM-10 cell line was infected with MoTN vector particles mixed with increasing concentrations of MoTN-PR3 vector particles. Both types of particles were obtained from PA317 cells infected with virus derived from transfected Psi-2 cells. As shown in Table 2 , the infectivity of MoTN vector particles is not affected by the presence of non-infectious MoTN-PR3 vector particles produced from PA317 cells. Up to a 5-fold excess of MoTN-PR3 vector particles failed to alter the titre of infectious MoTN vector particles. These results are not surprising, assuming that one infectious vector particle may be sufficient to infect a cell carrying perhaps 10 000 receptor molecules on its surface. MoTN-PR3 0
In summary, proviral 3′-LTR-driven cellular RNAs are transcribed in MoTN-PR3 packaging retroviral vector-infected cells. These RNAs contain the ψ signal and are therefore packaged into vector particles. Furthermore, the released vector particles are non-infectious. It is hypothesized that cells expressing nonretroviral RNAs containing a ψ signal could, upon infection by a retrovirus capable of recognizing this signal, release virus particles that fail to replicate in subsequent rounds of infection. We are now testing this hypothesis in an attempt to inhibit replication of human immunodeficiency virus type-1, which is responsible for acquired immune deficiency syndrome. This strategy may also be useful in inhibiting replication of other animal and plant RNA viruses.
In addition, the packaging retroviral vector pUCMoTN-PR3, allowing transcription and packaging of downstream cellular DNA sequences, would be of interest for identifying proviral DNA integration sites. Cell lines allowing expression of an insertionally activated gene(s) would also be useful for characterizing the structure/function of that gene (3) .
